Akira Matsumori
#160,912
Most Influential Person Now
Researcher
Akira Matsumori's AcademicInfluence.com Rankings
Akira Matsumoricomputer-science Degrees
Computer Science
#9236
World Rank
#9703
Historical Rank
Computational Linguistics
#2192
World Rank
#2214
Historical Rank
Machine Learning
#3991
World Rank
#4039
Historical Rank
Artificial Intelligence
#4326
World Rank
#4386
Historical Rank
Download Badge
Computer Science
Akira Matsumori's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Akira Matsumori Influential?
(Suggest an Edit or Addition)Akira Matsumori's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (11746)
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (8152)
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (7185)
- Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. (2001) (1639)
- Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. (1995) (871)
- Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice (2003) (590)
- Increased circulating cytokines in patients with myocarditis and cardiomyopathy. (1994) (554)
- Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. (1998) (447)
- Persistently Increased Serum Concentrations of Cardiac Troponin T in Patients With Idiopathic Dilated Cardiomyopathy Are Predictive of Adverse Outcomes (2001) (317)
- Evidence for a Role of Mast Cells in the Evolution to Congestive Heart Failure (2002) (244)
- Cardiac p300 Is Involved in Myocyte Growth with Decompensated Heart Failure (2003) (214)
- Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries. (1999) (198)
- Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. (1997) (191)
- DANCE, a Novel Secreted RGD Protein Expressed in Developing, Atherosclerotic, and Balloon-injured Arteries* (1999) (186)
- Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. (1996) (186)
- [Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model]. (1997) (185)
- Therapeutic Effect of Anti‐Tumor Necrosis Factor‐α Antibody on the Murine Model of Viral Myocarditis Induced by Encephalomyocarditis Virus (1994) (170)
- Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. (1997) (161)
- Dilated cardiomyopathy associated with hepatitis C virus infection. (1995) (158)
- Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure. (1994) (158)
- Cyclic stretch upregulates production of interleukin-8 and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in human endothelial cells. (1998) (155)
- Serial circulating concentrations of c‐reactive protein, interleukin (il)‐4, and il‐6 in patients with acute left heart decompensation (1999) (153)
- Treatment of experimental viral myocarditis with interleukin-10. (1999) (142)
- Neutralization of interleukin-1β in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling (2001) (125)
- Histone Acetyltransferase Activity of p300 Is Required for the Promotion of Left Ventricular Remodeling After Myocardial Infarction in Adult Mice In Vivo (2006) (125)
- Effects of prednisolone on acute viral myocarditis in mice. (1986) (121)
- Myocarditis and heart failure associated with hepatitis C virus infection. (2006) (114)
- Hepatitis C Virus from the Hearts of Patients with Myocarditis and Cardiomyopathy (2000) (111)
- Pioglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Attenuates Myocardial Ischemia/Reperfusion Injury in a Rat Model (2003) (108)
- The global burden of myocarditis: part 1: a systematic literature review for the Global Burden of Diseases, Injuries, and Risk Factors 2010 study. (2014) (105)
- Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction. (1996) (105)
- Mast cells cause apoptosis of cardiomyocytes and proliferation of other intramyocardial cells in vitro. (1999) (102)
- Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus. (1986) (102)
- Dilated cardiomyopathy (1992) (102)
- Molecular and immune mechanisms in the pathogenesis of cardiomyopathy--role of viruses, cytokines, and nitric oxide. (1997) (100)
- Hepatitis C virus infection and cardiomyopathies. (2005) (99)
- Amiodarone inhibits production of tumor necrosis factor-alpha by human mononuclear cells: a possible mechanism for its effect in heart failure. (1997) (98)
- Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. (1999) (96)
- Role of p38 Mitogen-Activated Protein Kinase in Neointimal Hyperplasia After Vascular Injury (2000) (96)
- Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain. (1997) (95)
- Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey (2002) (93)
- Improvement of quality of life with nocturnal oxygen therapy in heart failure patients with central sleep apnea. (2009) (85)
- Cardiac Persistence of Cardioviral RNA Detected by Polymerase Chain Reaction in a Murine Model of Dilated Cardiomyopathy (1992) (85)
- FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation. (1999) (85)
- Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis. (1999) (84)
- Dilated cardiomyopathy (2019) (82)
- Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy. (1996) (82)
- Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production. (1997) (81)
- A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in Japan. (2010) (81)
- Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy (1997) (81)
- Neutralization of interleukin-1beta in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling. (2001) (77)
- Treatment of viral myocarditis with ribavirin in an animal preparation. (1985) (77)
- Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril. (1996) (77)
- Expression and Distribution of Atrial Natriuretic Peptide in Human Hypertrophic Ventricle of Hypertensive Hearts and Hearts With Hypertrophic Cardiomyopathy (1991) (76)
- Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis. (1999) (75)
- High doses of digitalis increase the myocardial production of proinflammatory cytokines and worsen myocardial injury in viral myocarditis: a possible mechanism of digitalis toxicity. (1999) (75)
- New insights into the pathophysiological role for cytokines in heart failure. (1999) (74)
- Roles and Relationship of Macrophages and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in the Ischemic and Reperfused Rat Heart (2000) (74)
- Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure (2003) (73)
- Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production. (1994) (73)
- Cytokines in myocarditis and cardiomyopathies. (1996) (72)
- Hepatitis C virus infection and heart diseases: a multicenter study in Japan. (1998) (72)
- Prevention of viral myocarditis with recombinant human leukocyte interferon alpha A/D in a murine model. (1987) (71)
- Men's Health Study: epidemiology of erectile dysfunction and cardiovascular disease. (2003) (71)
- Chemokines and cardiovascular diseases. (2000) (70)
- Coxsackie virus B3 perimyocarditis in BALB/c mice: Experimental model of chronic perimyocarditis in the right ventricle (1980) (69)
- HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis. (2000) (66)
- Endothelin-1 and its receptor in hypertrophic cardiomyopathy. (1996) (63)
- ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular Injury* (2001) (61)
- Mast Cells Play a Critical Role in the Pathogenesis of Viral Myocarditis (2003) (61)
- An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis. (1994) (59)
- Differential modulation of cytokine production by drugs: implications for therapy in heart failure. (1996) (59)
- Independent origin of identical beta cardiac myosin heavy-chain mutations in hypertrophic cardiomyopathy. (1993) (59)
- Characterization of the human nebulette gene: a polymorphism in an actin-binding motif is associated with nonfamilial idiopathic dilated cardiomyopathy (2000) (57)
- Hepatitis C virus-associated tubulointerstitial injury. (2003) (57)
- Epidemiologic and clinical characteristics of cardiomyopathies in Japan: results from nationwide surveys. (2002) (56)
- Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy. (1998) (56)
- Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus. (2003) (54)
- Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. (1997) (54)
- Anti‐inflammatory effects of eplerenone on viral myocarditis (2009) (52)
- Mast Cell Tryptase in Mast Cell Granules Enhances MCP-1 and Interleukin-8 Production in Human Endothelial Cells (2005) (51)
- Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy (2003) (50)
- Suppression of cytokines and nitric oxide production, and protection against lethal endotoxemia and viral myocarditis by a new NF‐κB inhibitor (2004) (49)
- Myocardial metabolic changes in hypertrophic cardiomyopathy. (1996) (49)
- Hypertrophic cardiomyopathy as a manifestation of cardiac sarcoidosis. (2000) (48)
- Calcium channel blockers differentially modulate cytokine production by peripheral blood mononuclear cells. (2010) (47)
- Nifedipine inhibits activation of transcription factor NF-kappaB. (2000) (45)
- Indium-111-antimyosin antibody imaging for detecting different stages of myocardial infarction: comparison with technetium-99m-pyrophosphate imaging. (1990) (44)
- Contribution of endothelin-1 to myocardial injury in a murine model of myocarditis: acute effects of bosentan, an endothelin receptor antagonist. (1999) (43)
- Gene expression of cardiac mast cell chymase and tryptase in a murine model of heart failure caused by viral myocarditis. (2003) (43)
- Combined measurements of cardiac troponin T and N-terminal pro-brain natriuretic peptide in patients with heart failure. (2004) (43)
- Immediate increase in circulating hepatocyte growth factor/scatter factor by heparin. (1998) (41)
- Left ventricular pressure-volume relationship in a murine model of congestive heart failure due to acute viral myocarditis. (2002) (41)
- Cellular and molecular remodeling in a heart failure model treated with the β-blocker carteolol. (1999) (40)
- Protective role of interleukin-12 in viral myocarditis. (1997) (39)
- Myocardial uptake of antimyosin monoclonal antibody in a murine model of viral myocarditis. (1989) (39)
- Effects of Free Immunoglobulin Light Chains on Viral Myocarditis (2010) (39)
- Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis. (2001) (38)
- Inhibition of cytokine production by a new inotropic agent, vesnarinone, in human lymphocytes, T cell line, and monocytic cell line. (1994) (38)
- HLA-DRW4 antigen linkage in patients with hypertrophic obstructive cardiomyopathy. (1981) (37)
- Interferon treatment for dilated cardiomyopathy and striated myopathy associated with hepatitis C virus infection based on serial measurements of serum concentrations of cardiac troponin T. (2000) (37)
- Electrocardiographic findings in experimental myocarditis in DBA/2 mice: complete atrioventricular block in the acute stage, low voltage of the QRS complex in the subacute stage and arrhythmias in the chronic stage. (1984) (36)
- Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice. (2003) (36)
- Hepatocyte growth factor is a major mediator in heparin-induced angiogenesis. (1999) (36)
- Apical hypertrophic cardiomyopathy and hepatitis C virus infection. (1999) (35)
- Amlodipine inhibits the production of cytokines induced by ouabain. (2000) (35)
- Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments. (1995) (34)
- Serum cardiac troponin T and plasma brain natriuretic peptide in patients with cardiac decompensation (2002) (34)
- Calcium channel blockers and modulation of innate immunity (2011) (34)
- Inotropic agent vesnarinone inhibits cytokine production and E-selectin expression in human umbilical vein endothelial cells. (1995) (33)
- Pimobendan inhibits the activation of transcription factor NF-kappaB: a mechanism which explains its inhibition of cytokine production and inducible nitric oxide synthase. (2000) (33)
- The Role of Inflammatory Mediators in the Failing Heart: Immunomodulation of Cytokines in Experimental Models of Heart Failure (2001) (33)
- Measurement of serum concentrations of cardiac troponin T in patients with hypereosinophilic syndrome: a sensitive non-invasive marker of cardiac disorder. (2000) (32)
- Circulating hepatocyte growth factor as a diagnostic marker of thrombus formation in patients with cerebral infarction. (2002) (32)
- Role of hepatitis C virus in cardiomyopathies. (2006) (32)
- Dilated cardiomyopathy update: infectious-immune theory revisited (2013) (32)
- Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol. (1999) (31)
- Epidemiologic and Clinical Characteristics of Cardiomyopathies in Japan (2002) (30)
- The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy. (2005) (29)
- Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study (2006) (29)
- Immunochemical quantification of free immunoglobulin light chains from an analytical perspective (2006) (28)
- Autoimmune response in chronic ongoing myocarditis demonstrated by heterotopic cardiac transplantation in mice. (1996) (27)
- Hepatitis C Virus Infection and Hypertrophic Cardiomyopathy (1998) (27)
- Amiodarone inhibits interleukin 6 production and attenuates myocardial injury induced by viral myocarditis in mice. (2002) (27)
- The use of cytokine inhibitors. A new therapeutic insight into heart failure. (1997) (26)
- Mural thrombus in experimental viral myocarditis in mice: relation between thrombosis and congestive heart failure. (1986) (26)
- Efficacy of abciximab for patients undergoing balloon angioplasty: data from Japanese evaluation of c7E3 Fab for elective and primary PCI organization in randomized trial (JEPPORT). (2008) (26)
- Denopamine, a β1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-α production in the heart (1998) (25)
- Preformed Angiotensin II is Present in Human Mast Cells (2003) (25)
- Hepatitis C Virus and Cardiomyopathy (2000) (24)
- Experimental graft coronary artery disease in a murine heterotopic cardiac transplant model. (1995) (24)
- Hepatocyte growth factor and cardiovascular thrombosis in patients admitted to the intensive care unit. (2004) (24)
- Circulating hepatocyte growth factor as an early marker of arterial thrombus formation. (1998) (23)
- Prognosis and prognostic factors in patients with idiopathic dilated cardiomyopathy in Japan. (2008) (22)
- Autoantibodies against vimentin in a murine model of myocarditis. (1994) (22)
- Improvement of oxygen metabolism in ischemic myocardium as a result of enhanced external counterpulsation with heparin pretreatment for patients with stable angina (2004) (22)
- Serial evaluation of fatty acid metabolism in rats with myocardial infarction by pinhole SPECT (2001) (22)
- Role of Cytokines in Autoimmune Myocarditis and Cardiomyopathy (2001) (21)
- HL-A and hypertrophic cardiomyopathy. (1979) (21)
- Comparative study of201Tl-scintigraphic image and myocardial pathologic findings in patients with dilated cardiomyopathy (1996) (21)
- Hepatitis C virus infection in a patient with dermatomyositis and left ventricular dysfunction. (2000) (20)
- Anti-inflammatory therapy for heart failure. (2004) (20)
- Measurements of serum cardiac troponin T in patients with heart failure. (2003) (20)
- Increased Synthesis and Secretion of Atrial Natriuretic Polypeptide During Viral Myocarditis (1988) (20)
- Persistent uptake of indium-111-antimyosin monoclonal antibody in patients with myocardial infarction. (1990) (20)
- Myosin light chain I grade: a simple marker for the severity and prognosis of patients with acute myocardial infarction. (1998) (20)
- Inotropic agents differentially inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages. (1996) (20)
- Immunomodulation: a new horizon for medical treatment of heart failure. (1996) (20)
- Assessment of cardiac involvement of hepatitis C virus; tissue Doppler imaging and NTproBNP study. (2011) (18)
- Vesnarinone: a potential cytokine inhibitor. (1996) (18)
- Pathogenesis and preventive and therapeutic trials in an animal model of dilated cardiomyopathy induced by a virus. (1987) (18)
- Gelsolin and cardiac myocyte apoptosis: a new target in the treatment of postinfarction remodeling. (2009) (18)
- Serum concentration of cardiac troponin T in patients with cardiomyopathy: a possible mechanism of acute heart failure (1998) (18)
- Symposium on clinical aspects in hepatitis virus infection. 5. Clinical practice of hepatitis: myocardial diseases, nephritis, and vasculitis associated with hepatitis virus. (2001) (18)
- Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early? (2020) (18)
- Thrombosis Increases Circulatory Hepatocyte Growth Factor by Degranulation of Mast Cells (2002) (18)
- Vesnarinone prolongs survival and reduces lethality in a murine model of lethal endotoxemia. (1994) (17)
- Increased serum N‐terminal pro‐B‐type natriuretic peptide and left ventricle diastolic dysfunction in patients with hepatitis C virus infection (2012) (17)
- Cardiomyopathies and heart failure : biomolecular, infectious, and immune mechanisms (2003) (17)
- Inhibitory effects of Pycnogenol® on hepatitis C virus replication. (2015) (17)
- Cetirizine a histamine H1 receptor antagonist improves viral myocarditis (2010) (16)
- The biomarker N-terminal pro-brain natriuretic peptide and liver diseases. (2011) (16)
- French maritime pine bark extract inhibits viral replication and prevents development of viral myocarditis. (2007) (16)
- Significant regional heterogeneity of coronary flow reserve in paediatric hypertrophic cardiomyopathy (2000) (16)
- Immunomodulation by an adenylate cyclase activator, NKH477, in vivo and vitro. (1996) (16)
- Global alert and response network for hepatitis C virus-derived heart diseases: A call to action (2009) (15)
- Hepatitis C virus and cardiomyopathy. (2001) (15)
- Lessons from animal experiments in myocarditis. (1992) (15)
- Antimyosin antibody imaging in clinical myocarditis and cardiomyopathy: principle and application. (1996) (14)
- Hepatitis C virus infection manifesting as tubulointerstitial nephritis, cardiomyopathy, and hepatitis. (2000) (14)
- Cardiomyopathies and Heart Failure (2003) (13)
- Detection of adriamycin cardiotoxicity with indium-111 labeled antimyosin monoclonal antibody imaging. (1991) (13)
- Effect of immunostimulant therapy on acute viral myocarditis in an animal model. (1992) (13)
- HLA‐DPβ chain may confer the susceptibility to hepatitis C virus‐associated hypertrophic cardiomyopathy (2007) (13)
- Myocardial involvement in coronavirus disease 19 (2020) (13)
- Nifedipine inhibits the activation of inflammatory and immune reactions in viral myocarditis. (2009) (13)
- Heparin accelerates liver regeneration following portal branch ligation in normal and cirrhotic rats with increased plasma hepatocyte growth factor levels. (2002) (13)
- Circulating hepatocyte growth factor as a marker of thrombus formation in unstable angina pectoris. (2000) (13)
- Heminephrectomy Causes the Progression of Glomerulosclerosis and Apoptosis in High IgA Strain ddY Mice (2002) (12)
- Newer aspects of pathogenesis of heart failure: hepatitis C virus infection in myocarditis and cardiomyopathy. (1996) (12)
- Animal Models for Therapeutic Trials of Viral Myocarditis: Effect of Ribavirin and Alpha Interferon on Coxsackievirus B3 and Encephalomyocarditis Virus Myocarditis (1988) (12)
- Treatment Options in Myocarditis (2007) (12)
- Endothelin antagonism with bosentan: current status and future perspectives. (2006) (12)
- Roles of Hepatocyte Growth Factor and Mast Cells in Thrombosis and Angiogenesis (2004) (12)
- Apoptosis in congestive heart failure induced by viral myocarditis in mice (1997) (11)
- Leukocytes are the major target of hepatitis C virus infection: Possible mechanism of multiorgan involvement including the heart (2010) (11)
- Guideline for Diagnosing Chronic Myocarditis (1996) (11)
- Cytokine gene expression during the development of graft coronary artery disease in mice. (1999) (11)
- Mural thrombi in mice with acute viral myocarditis. (1985) (11)
- A pathogenic mechanism of chronic ongoing myocarditis. (1996) (11)
- Treatment Options in Myocarditis What We Know from Experimental Data and How It Translates to Clinical Trials (11)
- [Men's health study: current status of erectile dysfunction of 6,112 ambulatory patients at general practitioners offices in Japan]. (2003) (11)
- Mechanism and significance of myocardial uptake of antimyosin antibody in myocarditis and cardiomyopathy: clinical and experimental studies. (1993) (10)
- Role of p 38 Mitogen-Activated Protein Kinase in Neointimal Hyperplasia After Vascular Injury (2000) (10)
- Calcium channel blocker-induced protection against cardiovascular damage. (1997) (10)
- Successive infection of coxsackievirus B3 and encephalomyocarditis virus: An animal model of chronic myocarditis (1992) (10)
- Prognostic significance of indium-111 antimyosin antibody uptake in patients with dilated and hypertrophic cardiomyopathy (1991) (10)
- Prolongation of murine cardiac allograft survival with vesnarinone. (1997) (10)
- Comparative study of 201Tl-scintigraphic image and myocardial pathologic findings in patients with dilated cardiomyopathy. (1996) (9)
- REDUCED HIGH SERUM HEPATOCYTE GROWTH FACTOR LEVELS AFTER SUCCESSFUL CARDIOVERSION IN PATIENTS WITH ATRIAL FIBRILLATION (2004) (9)
- Immunoglobulin free light chains as an inflammatory biomarker of heart failure with myocarditis. (2020) (9)
- Indium-111 antimyosin antibody imaging and thallium-201 imaging--a comparative myocardial scintigraphic study using single-photon emission computed tomography in patients with myocarditis and dilated cardiomyopathy. (1997) (9)
- Time course of myocardial infarction evaluated by indium-111-antimyosin monoclonal antibody scintigraphy: clinical implications and prognostic value. (1992) (9)
- Autoantibodies against cardiac troponin I in patients presenting with myocarditis (2011) (9)
- Pharmacokinetics of indium-111-labeled antimyosin monoclonal antibody in murine experimental viral myocarditis. (1990) (9)
- Immunomodulating therapy in experimental myocarditis (2004) (8)
- Virus vaccine and passive immunization for the prevention of viral myocarditis in mice. (1987) (8)
- Hydrocortisone reduces restenosis after stenting of small coronary arteries. (2004) (8)
- Clinical pictures of 35 cases with eosinophilic myocarditis (2004) (8)
- HLA in hypertrophic cardiomyopathy and rheumatic heart disease. (1979) (8)
- Effects of Pranidipine, a Calcium Channel Antagonist, in an Avian Model of Heart Failure (1999) (8)
- The effect of hydrocortisone on reducing rates of restenosis and target lesion revascularization after coronary stenting less than 3 mm in stent diameter. (2003) (7)
- Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart. (1998) (7)
- Pathogenesis of myocardial injury in myocarditis and cardiomyopathy. (1991) (7)
- 111In monoclonal antimyosin antibody imaging: imaging of myocardial infarction and myocarditis. (1990) (7)
- Immunoglobulin free light chains: an inflammatory biomarker of diabetes (2020) (7)
- Diagnosis and treatment of HCV heart diseases (2021) (7)
- Detection of viral RNA in experimental coxsackievirus B3 myocarditis of mice using the polymerase chain reaction. (1992) (6)
- Relation between myoglobin and cardiac dysfunction in myocarditis--immunohistochemical study of endomyocardial biopsy specimens. (1991) (6)
- Proinflammatory cytokine inhibitor prolongs the survival of rats with heart failure induced by pressure overload. (2001) (6)
- Role of cytokines in the syndrome of heart failure. (1996) (6)
- The role of NF-kappaB in the pathogenesis of heart failure and endotoxemia (2004) (6)
- Cytokines in Experimental Myocarditis (2003) (5)
- Dilated phase of hypertrophic cardiomyopathy with mid-ventricular obstruction after 20-year follow-up. (2000) (5)
- 4. Viral Myocarditis and Cardiomyopathy (1989) (5)
- Immunoglobulin Free Light Chains as Inflammatory Biomarkers of Atrial Fibrillation. (2020) (5)
- The Global Burden of Myocarditis (2014) (5)
- Animal Models for Therapeutic Trials of Viral Myocarditis (1993) (5)
- Cellular and molecular remodeling in a heart failure model treated with the b-blocker carteolol (1999) (5)
- Protective effects of Mu-Fang-Ji-Tang against myocardial injury in a murine model of congestive heart failure induced by viral myocarditis. (1998) (5)
- Cytokines in myocarditis and dilated cardiomyopathy (2002) (4)
- [Myocardial uptake ratio of iodine-123 labeled beta-methyl iodophenylpentadecanoic acid (123I-BMIPP) in relation to the concentration of the substrates of energy]. (1995) (4)
- Pimobendan inhibits the activation of transcription factor NF-κB (2000) (4)
- Novel Biomarkers of Inflammation for the Management of Diabetes: Immunoglobulin-Free Light Chains (2022) (4)
- Role of Inflammation in Heart Failure: New Insights into Pathogenesis and Treatment (2005) (3)
- Treatment of coxsackievirus B3 myocarditis by immunoactive peptide in an animal model. (1992) (3)
- [Roles of cytokines in the pathogenesis of heart failure]. (2003) (3)
- Beneficial effect of amrinone on murine cardiac allograft survival (1995) (3)
- [Hepatitis C virus infection and cardiomyopathy]. (1999) (3)
- Role of substance P in viral myocarditis in mice (2010) (3)
- [Immunological background of patients with dilated cardiomyopathy and myocarditis: clinical and experimental studies]. (1986) (3)
- Hepatitis Cvirus and Cardiomyopathy (2003) (3)
- Steroid treatment in viral myocarditis in mice: with special reference to serial changes in lymphocyte subsets (1987) (2)
- Effects of prednisolone on encephalomyocarditis virus myocarditis in mice (1985) (2)
- Lessons learned from experimental myocarditis (2012) (2)
- Genes of the Major Histocompability Complex Class II Influence the Phenotype of Cardiomyopathies Associated With Hepatitis C Virus Infection (2003) (2)
- OE-091 Detection of cardiac sarcoidosis with delayed-enhanced MRI : Comparison with nuclear imaging(X-ray/CT/MRI/DSA 1 (I) : OE11)(Oral Presentation (English)) (2004) (2)
- Transition from Compensated to Decompensated Cardiac Hypertrophy (1999) (2)
- Myocarditis : past , present and future (2012) (2)
- Electrocardiographic findings in experimental murine myocarditis--arrhythmias in the chronic stage. (1983) (2)
- 2) ELECTROCARDIOGRAPHIC FINDINGS IN EXPERIMENTAL MYOCARDITIS : a) ENCEPHALOMYOCARDITIS VIRUS MYOCARDITIS IN MICE b) COXSACKIE B_1 VIRUS MYOCARDITIS IN GOLDEN HAMSTERS (1982) (2)
- Heart Failure and Cardiomyopathies in Japan (2006) (2)
- The effect of hypertension, aging and benidipine on arterial elasticity in elderly hypertensives (2010) (2)
- Immunomodulation of Cytokines in Experimental Models of Heart Failure (2001) (2)
- [Idiopathic cardiomyopathy--pathogenesis]. (2000) (1)
- [Indium-111 antimyosin monoclonal antibody uptake in patients with cardiomyopathy and myocarditis]. (1990) (1)
- THE INCIDENCE OF THE LEFT VENTRICULAR HYPERTRONTROPHY IN BORDERLINE HYPERRTENSIVE AND AGE-MATCHED NORMOTENSIVE MALES. A TEN YEAR FOLLOW-UP STUDY : Hypertension I : Ist Auditorium : Proceedings of the 43rd Annual Meeting of the Japanese Circulation Society, Tokyo, 1979 (1979) (1)
- Immunoglobulin Free Light Chains: A Biomarker of Diabetes (2019) (1)
- Prevention of encephalomyocarditis virus myocarditis in mice by inactivated virus vaccine (1985) (1)
- Forum—Letter to the editorReply (1981) (1)
- Immunomodulating Effects as New Aspects of a Positive Inotropic Agent (1996) (1)
- -0306-AN ANIMAL MODEL OF CHRONIC MYOCARDITIS : SUCCESSIVE INFECTION WITH COXSACKIEVIRUS AND ENCEPHALOMYOCARDITIS VIRUS IN MICE (1990) (1)
- Experimental Viral Myocarditis: Immunopathogenetic Aspects (1990) (1)
- Thrombosis and angiogenesis. (2005) (1)
- MON-LB681: Prevention of Nutritional Deficiencies in Chronic Hepatitis C Patients- New Virus Removal Treatment (2019) (1)
- Large Animal Model of Viral Myocarditis (2003) (1)
- [Comparative study of 201Tl-scintigraphic image and endomyocardial biopsy findings in patients with dilated cardiomyopathy]. (1994) (1)
- Pancreatic uptake of 99mTc stannous pyrophosphate in experimental viral pancreatitis in mice (1981) (1)
- Detection of cardioviral RNA by polymerase chain reaction in a murine model of dilated cardiomyopathy (1992) (1)
- Elevated circulating levels of tumor necrosis factor in patients with mitral valve disease and ventricular septum defect (2007) (1)
- [Cytokine antagonists and endothelin antagonists for therapy of heart failure]. (2005) (1)
- The protection of coenzyme Q10 against experimental viral myocarditis in mice. (1984) (1)
- Role of inflammation in heart failure (2008) (1)
- [Detection of viral genomes in myocarditis]. (1995) (1)
- Cardiovascular Factors Associated with COVID-19 from an International Registry of Primarily Japanese Patients (2022) (1)
- Emerging treatments for viral myocarditis. (2005) (1)
- [Metabolism of failing myocardium]. (1993) (1)
- Corrigendum to ‘Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure’ [Eur J Heart Fail 5 (2003) 699–677] (2004) (1)
- Thrombosis in experimental viral myocarditis in mice: time of appearance and relationships among thrombosis, congestive heart failure and cavity dimensions (1987) (1)
- [Myocardial, renal, and vascular lesions caused by hepatitis viruses]. (2000) (1)
- -424- ATRIAL NATRIURETIC POLYPEPTIDE IN EXPERIMENTAL VIRAL MYOCARDITIS : -IMMUNOCYTOCHEMICAL STUDY (1987) (1)
- O-8 Cardiac nuclear acetylation by p300 is involved in myocyte growth with decompensated heart failure (2002) (1)
- Activation of chymase in the mouse heart of viral myocarditis (1999) (1)
- Detection of circulating tumor necrosis factor in myocarditis and dilated cardiomyopathy (1992) (1)
- Immunomodulatory therapy and survival with cardiac disease (1996) (0)
- The role of autoantibodies against cardiac troponin I in autoimmune dilated cardiomyopathy (2004) (0)
- Management of Atrial Fibrillation Using Immunoglobulin Free Light Chains, Novel Biomarkers of Inflammation (2022) (0)
- Therapeutic Effects of FTY 720 , a New Immunosuppressive Agent , in a Murine Model of Acute Viral Myocarditis (2016) (0)
- Use of 2-amino-2- (2- (4-octylphenyl) ethyl) propane-1,3-diol to prevent or treat viral myocarditis. (2000) (0)
- -P47-CLINICAL TRIAL OF IN-111-ANTIMYOSIN ANTIBODY IMAGING IN PATIENTS WITH MYOCARDITIS AND MYOCARDIAL INFARCTION : RI : FREE COMMUNICATIONS(III) : PROCEEDINGS OF THE 53th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY (1989) (0)
- Role of myocardial lymphangiogenesis in heart failure (2008) (0)
- HCV Cardiomyopathy; raising a regional alert (2012) (0)
- [Clinical trial of 111In-antimyosin antibody imaging: (2). Imaging of myocardial infarction and myocarditis]. (1989) (0)
- APSC2015-1303 Elevated Immunoglobulin Serum Free Light Chains in Heart Failure (2015) (0)
- Expression of Stem Cell Factor Is Increased in Idiopathic and Ischemic Cardiomyopathy (2003) (0)
- Hepatitis C Virus infection as a cause of heart failure and myocarditis in the myocarditis treatment trial (2004) (0)
- Nf-κB activation and enhanced cytokine gene expression occurs in the non-infarcted myocardium of rat hearts (1998) (0)
- [Idiopathic cardiomyopathy]. (2020) (0)
- Measurements of serum cardiac troponin T and plasma brain natriuretic peptide in patients with heart failure (2002) (0)
- International Academy of Cardiovascular Sciences Japan Section Meeting July 14 to 15, 2007, Kyoto, Japan. (2007) (0)
- INSIGHTS INTO THE PATHOPHYSIOLOGY OF HEART FAILURE BASED ON A NEW CONCEPT * (2001) (0)
- -0604-DETECTION OF ANTIMYOSIN MONOCLONAL ANTIBODYFAB IN THE MYOCARDIAL CELLS IN THE ACUTE AND CHRONIC STAGES OF EXPERIMENTAL MYOCARDIAL INFARCTION USING IMMUNOHISTOCHEMISTRY (1990) (0)
- [Effect of angiotensin II receptor antagonist on heart failure]. (2004) (0)
- Lymphangiogenesis in inflammatory and Ischemic Heart Diseases(Inflammatory Heart Disease-Update and Future Perspective-, The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
- HCV cardiomyopathy : more data for underestimated aetiology of cardiac diseases in Africa (2011) (0)
- Cardiomyopathies and Myocarditis (2007) (0)
- Heart failure and renin-angiotensin system (1994) (0)
- Targeting Inflammation in the Diagnosis, Management, and Prevention of Cardiovascular Diseases (2022) (0)
- [Molecular mechanisms of extrahepatic lesions]. (2004) (0)
- [Anti-TNF-alpha therapy for heart failure: etanercept, infliximab]. (2007) (0)
- Insulin-like growth factor-1 boosts viral titers and aggravates the course of acute viral myocarditis in mice (1998) (0)
- -0820-EXPRESSION OF ATRIAL NATRIURETIC POLYPEPTIDE IN THE VENTRICLE OF THE HUMAN HEARTS WITH MYOCARDIAL INFARCTION : THE 54th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY (1990) (0)
- Time Course of IL-10 Levels in the Heart (1999) (0)
- Myocarditis Due to Coxsackievirus B3, Mouse (1991) (0)
- ANEURYSMAL FORMATION AND ELECTROCARDIOGRAPHIC ABNORMALITY IN EXPERIMENTAL VIRAL MYOCARDITIS : Cardiomyopathy (I) : 46th Annual Scientific Meeting, Japanese Circulation Society (1982) (0)
- [Clinical trial of 111In-antimyosin antibody imaging: (5). Follow-up study and its safety]. (1990) (0)
- [A case of acute myocarditis immunologically studied with monoclonal antibody]. (1989) (0)
- Mast cell granules induce endothelial production of chemokines (2002) (0)
- Beneficial Effect of Carteolol in Mice (2005) (0)
- -468-CARDIAC IMAGING WITH INDIUM-111 LABELLED ANTIMYOSIN MONOCLONAL ANTIBODY (AMA) OF ACUTE MYOCARDIAL INFARCTION AND MYOCARDITIS : CLINICAL APPLICATION : Ischemic Heart Disease I : FREE COMMUNICATIONS(II) : PROCEEDINGS OF THE 53th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY (1989) (0)
- JS4-3 Evaluation of Increased Level of NT-proBNP in Viral Hepatitis Patients in China (2009) (0)
- β-ADRENERGIC BLOCKADE IN DILATED CARDIOMYOPATHY(DCM)/EFECTS OF CARTEOLOL THERAPY (1993) (0)
- The effect of beta-adrenergic blockade in dilated cardiomyopathy — a questionnaire study in Japan (2005) (0)
- Cytokines in the pathogenesis of heart failure (1996) (0)
- [Role of cytokines in etiological mechanism of congestive heart failure]. (1995) (0)
- Echocardiographic features, left heart events and the spatial ventricular gradient in a case with intermittent type A Wolff-Parkinson-White syndrome. (1978) (0)
- Myocarditis and Pericarditis (2021) (0)
- Implications of Cytokine Inhibition for the Drug Therapy of Heart Failure (1997) (0)
- A patient with hypertrophic cardiomyopathy accompanied by right ventricular dilation of unknown cause. (1999) (0)
- Correction to: Immunoglobulin free light chains: an inflammatory biomarker of diabetes (2020) (0)
- [Improved cineangiographic evaluation of hypertrophic cardiomyopathy by biventriculography with angled projection]. (1983) (0)
- IS075 Antiviral Effect and Improved Survival by Carvedilol Via Interferon-γ in Heart Failure From Myocarditis (1998) (0)
- 0895 EFFECT OF ENDOTHELIN RECEPTOR ANTAGONIST, TAK-044 ON SURVIVAL RATE AND MYOCARDIAL DAMAGE IN A MURINE MODEL OF VIRAL MYOCARDITIS (1997) (0)
- IS014 Role of Interleukin-10 in a murine model of congestive heart failure induced by viral myocarditis (1999) (0)
- IS009 GATA-5 Is Involved in Leukemia Inhibitory Factor-Induced Hypertrophy Signalling in Cardiac Myocytes (1998) (0)
- -1169-INDIUM-111 LABELED ANTIMYOSIN MONOCLONAL ANTIBODY FAB IMAGING : REPEATED STUDY AND ITS SAFETY : THE 54th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY (1990) (0)
- 26) ANALYSIS OF ARRHYTHMIAS BY 24-HOUR ELECTROCARDIOGRAPHIC MONITORING IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (1986) (0)
- 36) Echocardiographic, phonocardiographic, mechanocardiographic and vectorcardiographic findings observed in a patient with intermittent type A Wolff-Parkinson-White syndrome : 第43回日本循環器学会近畿地方会 (1980) (0)
- Candesartan may prevent diabetes in people with heart failure. Commentary. (2005) (0)
- [Viral myocarditis and autoimmunity]. (1997) (0)
- Matsumori Makoto Kinoshita , Tadashi Miyamoto , Naohiro Ohashi , Shigetake Sasayama and Akira Cells Thrombosis Increases Circulatory Hepatocyte Growth Factor by Degranulation of Mast (2002) (0)
- -P239- PREVENTION OF COXSACKIEVIRUS MYOCARDITIS WITH RECOMBINANT ALPHA INTERFERON IN MICE (1987) (0)
- Cardiac Nuclear Hyper-Acetylation by Inhibiting Histone Deacetylase Facilitates Left Ventricular Remodeling Following Myocardial Infarction In Adult Mice in Vivo (2003) (0)
- The immunohistochemical evidence of antimyosin antibody uptake by myocytes at the subacute to chronic stage of experimental myocarsial infarction in rabbits (1992) (0)
- Clinical Significance of Hepatocyte Growth Factor in Acute Coronary Syndrome (2002) (0)
- 17)THE SPATIAL VENTRICULAR GRADIENT: VENTRICULAR PREMATURE CONTRACTIONS : THE II CONFERENCE ON VECTORCARDIOGRAPHY (1977) (0)
- Monocyte Chemoattractant Protein-1 / Monocyte Chemotactic and Activating Factor − (1999) (0)
- -0423-BIODISTRIBUTION OF ^ I-LABELED METAIODOBENZYLGUANIDINE (MIBG) IN THE HEART IN A MURINE MODEL OF MYOCARDITIS (1990) (0)
- [Effect of IFN treatment for extrahepatic manifestations]. (2004) (0)
- Attenuation of myocardial ischemia / reperfusion injury in rats by thiazolidinedione (2002) (0)
- Role of Mast Cells in the Pathogenesis of Heart Failure due to Myocarditis: Mast Cells as a Therapeutic Targets (2004) (0)
- [Imaging of myocardial necrosis--indium-111 labeled antimyosin monoclonal antibody imaging using single-photon emission computed tomography]. (1994) (0)
- COXSACKIE VIRUS B3 PERIMYOCARDITIS IN BALB/c MICE. : A STUDY ON HISTOPATHOLOGY AND MYOCARDIAL UPTAKE OF 99mTc-PYP : Myocarditis, Digitalis : IInd Auditorium : Proceedings of the 43rd Annual Meeting of the Japanese Circulation Society, Tokyo, 1979 (1979) (0)
- Gene Therapy for Acute Viral Myocarditis Transferring Soluble c-Kit (sc-kit) Gene by in Vivo Electroporation (2003) (0)
- Immunostimulant therapy on acute viral myocarditis in an animal model (1992) (0)
- 53) The diagnostic usefulness of the vectorcardiogram. 1. Detection of small inferior wall myocardial infarction : 第43回日本循環器学会近畿地方会 (1980) (0)
- 12) HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY IN THE ELDERLY (1982) (0)
- Coronary Reperfusion and Cytokines (1998) (0)
- Beneficial Effects of Arotinolol, a β-blocker, in Experimental Heart Failure (2007) (0)
- ! e biomarker N-terminal pro-brain natriuretic peptide and liver diseases (2011) (0)
- Effects of Benidipine, a Calcium Antagonist, on the progression of left ventricular remodeling in a Murine Model of Dilated Cardiomyopathy (2008) (0)
- e0677 Increased plasma NTerminal proBType natriuretic peptide in patients with hepatitis C virus infection (2010) (0)
- Left ventricular remodeling and chronic heart failure after myocardial infarction in mice (1999) (0)
- ELECTROCARDIOGRAPHIC FINDINGS OF ENCEPHALOMYOCARDITIS VIRAL MYOCARDITIS IN MICE : LOW VOLTAGE OF QRS COMPLEX IN SUBACUTE STAGE AND ARRHYTHMIAS IN CHRONIC STAGE : PROCEEDINGS OF THE 47th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY : Cardiomyopathy (1983) (0)
- Overexpression of the JAB/SOCS-1 in Host T Cell Prevents Acute Cardiac AI log raft Failure in Mice (2003) (0)
- 693 A new NF‐kB inhibitor suppressed production of cytokines and nitric oxide, and protected against heart failure due to viral myocarditis (2003) (0)
- COMPARATIVE STUDY OF ^ Tl-SCINTIGRAPHIC IMAGE AND ENDOMYOCARDIAL BIOPSY FINDINGS IN PATIENTS WITH DILATED CARDIOMYOPATHY (1993) (0)
- Immunoglobulin free light chains: an inflammatory biomarker of diabetes (2020) (0)
- 14) EFFECTS OF PREDNISOLONE ON EXPERIMENTAL MYOCARDITIS (1983) (0)
- IMMUNOLOGICAL BACKGROUNDS IN PATIENTS WITH DILATED CARDIOMYOPATHY AND MYOCARDITIS : CLINICAL AND EXPERIMENTAL STUDIES : Myocardial Disease (I) : FREE COMMUNICATIONS (I) : PROCEEDINGS OF THE 49th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY (1985) (0)
- [Not Available]. (1997) (0)
- -153-DISTRIBUTION OF ATRIAL NATRIURETIC POLYPEPTIDE AND ITS RELATIONS WITH FUNCTION AND HISTOLOGY IN DILATED CARDIOMYOPATHY : IMMUNOHISTOCHEMICAL STUDY OF ENDOMYOCARDIAL BIOPSY : Cardiomyopathy : FREE COMMUNICATIONS(I) : PROCEEDINGS OF THE 53th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION S (1989) (0)
- 2 Role of Viruses in the Pathogenesis of Dilated Cardiomyopathy(The Cause of Dilated Cardiomyopathy : Inflammation or Genetic,Controversy 2 (C-2) (M),Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation Society) (2008) (0)
- Immunohistochemical Study of the Endomyocardial Biopsy Specimens (2005) (0)
- Myocarditis : past, present and future (Professor Tohru Izumi Retirement Symposium : Heart Failure and Myocardial Disease : Message to the Next Generation) (2013) (0)
- P938 Early diagnosis of thrombosis by circulating hepatocyte growth factor in patients with unstable angina pectoris and other deseases (2003) (0)
- Natural history of juvenile essential hypertension (1982) (0)
- Abstract 5883: Role of Myocardial Lymphangiogenesis in Hypertensive Heart Failure (2008) (0)
- Clinical trial of indium 111 labeled antimyosin antibody imaging 4. effect of reperfusion in acute myocardial infarction (1990) (0)
- FRS-133 Reconstitution of Mast Cells to Its Deficient Mice Deteriorates Histopathology of Viral Myocarditis : Mast cells as A Possible Therapeutic Target(Myocardial Disease (M) : FRS16)(Featured Research Session (English)) (2004) (0)
- [Pathogenesis of and therapy for extrahepatic lesions: myocarditis and cardiomyopathy]. (2004) (0)
- -P619- EFFICACY AND SAFETY OF TCV-116, AN ANGIOTENSIN II RECEPTOR ANTAGONIST, IN PATIENTS WITH CHRONIC HEART FAILURE(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY) (1995) (0)
- Hepatitis C Virus Infection in Hypertrophic or Dilated Cardiomyopathy (2000) (0)
- Diarylmethylpiperazines as a prophylactic or therapeutic agent for viral myocarditis (2003) (0)
- 10) IMPROVED CINEANGIOGRAPHIC EVALUATION OF HYPERTROPHIC CARDIOMYOPATHY BY ANGLEDBIVENTRICULOGRAPHY (1983) (0)
- [Clinical trial of 111In-antimyosin antibody imaging: (3) Comparison with 99mTc-pyrophosphate imaging]. (1989) (0)
- IS056 Recombinant hepatocyte growth factor induces capillary endothelial regeneration in a rat model of myocardial ischemia and reperfusion (1998) (0)
- Prognostic significant of indium-111 antimyosin antibody uptake in patients with dilated and hypertrophic cardiomyopathy. (1991) (0)
- Myocardial Lymphangiogenesis in a Murine Model of Viral Myocarditis (2005) (0)
- Detection of viral RNA in the heart in experimental coxsackievirus B3 myocarditis of mice using the polymerase chain reaction (1992) (0)
- OJ-507 Autoantibodies against Cardiac Troponin I are the Critical Role for Autoimmune Dilated Cardiomyopathy(Cardiomyopathy, Basic (M) : OJ62)(Oral Presentation (Japanese)) (2004) (0)
- Abstract 185: Role of Lymphangiogenic Factors in a Murine Model of Viral Myocarditis (2006) (0)
- IMMUNOPATHOLOGICAL FINDNGS OF CHRONIC STAGE OF VIRAL MYOCARDITIS IN MICE (1994) (0)
- Effect of on density in a murine model of dilated cardiomyopathy (1992) (0)
- Time Courseof MyocardialInfarctionEvaluated by Indium-i11-AntimyosinMonoclonal AntibodyScintigraphy: ClinicalImplicationsand PrognosticValue (1992) (0)
- A new NF-kB inhibitor suppressed production of cytokines and protected against heart failure and lethal endotoxemia (2003) (0)
- Further experiences in clinical use of a new flexible endomyocardial biopsy catheter for the left ventricle (1978) (0)
- [Impaired left ventricular function in a patient with visual disturbance]. (1998) (0)
- Plasma HGF Measurement After CP 48 / 80 Injection in Wistar and Ws Rats (2002) (0)
- The Key Role of Mast Cells in the Evolution to Congestive Heart Failure (2003) (0)
- Cytokines and Heart Failure: Immunomodulating Agents for the Management of Heart Failure (1996) (0)
- PresentationsRole of Lymphangiogenesis in Experimental Ischemic Heart Failure (2006) (0)
- Remedy for heart diseases (1997) (0)
- P-8 MYOCARDITIS AND RELATED DISORDERS IN ASIA (2007) (0)
- P-80 Effects of Lymphangiogenic Factors on Left Ventricular Function in Heart Diseases (2009) (0)
- Correction to: Immunoglobulin free light chains: an inflammatory biomarker of diabetes (2020) (0)
- Cytokines in heart failure Pathophysiological roles and therapeutic implications (1998) (0)
- Gene Expression of Cardiac Mast Cell Chymase and Tryptase in a Murine Model of Heart Failure Due to Viral Myocarditis (2003) (0)
- Expression of cardiotrophin-1 during the transition from acute myocarditis to dilated cardiomyopathy (1999) (0)
- IS095 MOLECULAR AND IMMUNE MECHANISMS IN THE PATHOGENESIS OF MYOCARDITIS AND CARDIOMYOPATHY ROLE OF HEPATITIS CVIRUS, CYTOKINES, AND NITRIC OXIDE (1998) (0)
- [Clinical trial of 111In-antimyosin antibody imaging: (4). Effect of reperfusion in acute myocardial infarction]. (1990) (0)
- SL4 Global Alert and Response Network for Hepatitis C Virus-Derived Heart Diseases (2009) (0)
- ANALYSIS OF THE VIRAL GENOME IN THE HEART OF EXPERIMENTAL COXSACKIEVIRUS B3 MYOCARDITIS OF MICE BY NORTHERN BLOTTING : Cardiomyopathy, Myocarditis : 53 Annual Scientific Meeting, Japanese Circulation Society (1989) (0)
- -P237- SERIAL MONITORING OF LYMPHOCYTE SUBSETS IN PERIPHERAL BLOOD AND MYOCARDIUM IN SITU IN EXPERIMENTAL VIRAL MYOCARDITIS (1987) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Akira Matsumori?
Akira Matsumori is affiliated with the following schools:
